OmniGen-AF®, a unique patented product that helps support the immune function in dry, pre-fresh and lactating dairy cattle, has been introduced throughout Canada by Phibro Animal Health Corporation.

Dairy cows face expected and unexpected stress events year-round. Stress factors may include the demands of pregnancy and calving, the onset of lactation, feed quality challenges, weather changes or extremes and disease or pathogen challenges. OmniGen-AF is recommended to be fed daily.

Research conducted at universities in the United States and other countries and by Phibro, along with numerous field studies, has shown that OmniGen-AF works to help support the innate immune system. Healthy immune function may result in fewer health events, such as mastitis and metritis, and in turn may lead to higher milk production and fewer unplanned culls.

"For several years, OmniGen-AF demand has been growing in the United States and other countries as dairy owners seek solutions for improved herd health and productivity," said product manager Rod Isham. "We are pleased to bring OmniGen-AF to Canada, where there is strong interest by dairy producers in optimizing their results."

Isham noted that OmniGen-AF may be included in pelleted or non-pelleted complete and concentrate dairy feeds, dairy premixes or added directly into total mixed rations. For additional information, Canadian dairy producers can contact a Phibro Dairy Technical Specialist or visit to review key technical resources, view videos on key research and field studies and view producer testimonials.

Phibro currently markets OmniGen-AF in the United States, Canada, Brazil, Mexico, Australia, the Netherlands, Denmark, Italy, Belgium, France, China, Japan, South Korea, Turkey and Israel.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. For more information, visit

Return to Industry Buzz.